Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Elham Ghanbarian

Showing results (11-20 of 26) with videos related to

Pageof 3
Sort By:
Medrxiv : the Preprint Server for Health Sciences|July 17, 2025
Sex Differences in Cognitive Performance in Alzheimer's Disease: Insights from the ADAS-Cog-13Mohan Liu, Khushi Bhatt, Mia F Giaever, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 25, 2025
BiomarkersElham Ghanbarian, Babak Khorsand, Laura A Rabin, et al.
Journal of Alzheimer'S Disease : JAD|April 6, 2026
Sex differences in cognitive performance in Alzheimer's disease: Insights from the ADAS-Cog-13Mohan Liu, Khushi Bhatt, Mia F Giaever, et al.
Clinical Neurology and Neurosurgery|October 7, 2025
Impact of anxiety and depression on migraine-related disability: Results from the Headache Assessment via Digital Platform in the United States (HeAD-US) studyAdalmina K Sarkar, Elham Ghanbarian, Kristina M Fanning, et al.
Journal of Alzheimer'S Disease : JAD|April 22, 2025
Cerebrospinal fluid inflammatory cytokines as prognostic indicators for cognitive decline across Alzheimer's disease spectrumElham Ghanbarian, Babak Khorsand, Kellen K Petersen, et al.
Medrxiv : the Preprint Server for Health Sciences|November 28, 2024
CSF inflammatory cytokines as prognostic indicators for cognitive decline across Alzheimer's disease spectrumElham Ghanbarian, Babak Khorsand, Kellen K Petersen, et al.
Neurology|March 25, 2025
A Machine Learning Approach to Predict Cognitive Decline in Alzheimer Disease Clinical TrialsBhargav T Nallapu, Kellen K Petersen, Tianchen Qian, et al.
Medrxiv : the Preprint Server for Health Sciences|May 18, 2026
CSF p-tau Predicts Asymmetric Hippocampal Atrophy in Cognitively Unimpaired Older AdultsElham Ghanbarian, Lukai Zheng, Tianchen Qian, et al.
Medrxiv : the Preprint Server for Health Sciences|June 12, 2026
APOE and amyloid-tau pathology in cognitively unimpaired older adultsCarlos Albarrán Morillo, Lukai Zheng, Elham Ghanbarian, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|May 28, 2026
Scalable markers for early cognitive decline: Plasma p-tau217, subjective cognitive concerns, and digital testing: Results from the A4/LEARN studiesBabak Khorsand, Devin Teichrow, Elham Ghanbarian, et al.
Pageof 3

Showing results (11-20 of 26) with videos related to

Sort By:
Pageof 3
Medrxiv : the Preprint Server for Health Sciences|July 17, 2025
Sex Differences in Cognitive Performance in Alzheimer's Disease: Insights from the ADAS-Cog-13Mohan Liu, Khushi Bhatt, Mia F Giaever, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 25, 2025
BiomarkersElham Ghanbarian, Babak Khorsand, Laura A Rabin, et al.
Journal of Alzheimer'S Disease : JAD|April 6, 2026
Sex differences in cognitive performance in Alzheimer's disease: Insights from the ADAS-Cog-13Mohan Liu, Khushi Bhatt, Mia F Giaever, et al.
Clinical Neurology and Neurosurgery|October 7, 2025
Impact of anxiety and depression on migraine-related disability: Results from the Headache Assessment via Digital Platform in the United States (HeAD-US) studyAdalmina K Sarkar, Elham Ghanbarian, Kristina M Fanning, et al.
Journal of Alzheimer'S Disease : JAD|April 22, 2025
Cerebrospinal fluid inflammatory cytokines as prognostic indicators for cognitive decline across Alzheimer's disease spectrumElham Ghanbarian, Babak Khorsand, Kellen K Petersen, et al.
Medrxiv : the Preprint Server for Health Sciences|November 28, 2024
CSF inflammatory cytokines as prognostic indicators for cognitive decline across Alzheimer's disease spectrumElham Ghanbarian, Babak Khorsand, Kellen K Petersen, et al.
Neurology|March 25, 2025
A Machine Learning Approach to Predict Cognitive Decline in Alzheimer Disease Clinical TrialsBhargav T Nallapu, Kellen K Petersen, Tianchen Qian, et al.
Medrxiv : the Preprint Server for Health Sciences|May 18, 2026
CSF p-tau Predicts Asymmetric Hippocampal Atrophy in Cognitively Unimpaired Older AdultsElham Ghanbarian, Lukai Zheng, Tianchen Qian, et al.
Medrxiv : the Preprint Server for Health Sciences|June 12, 2026
APOE and amyloid-tau pathology in cognitively unimpaired older adultsCarlos Albarrán Morillo, Lukai Zheng, Elham Ghanbarian, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|May 28, 2026
Scalable markers for early cognitive decline: Plasma p-tau217, subjective cognitive concerns, and digital testing: Results from the A4/LEARN studiesBabak Khorsand, Devin Teichrow, Elham Ghanbarian, et al.
Pageof 3